EXCESSIVE DAYTIME SLEEPINESS
Clinical trials for EXCESSIVE DAYTIME SLEEPINESS explained in plain language.
Never miss a new study
Get alerted when new EXCESSIVE DAYTIME SLEEPINESS trials appear
Sign up with your email to follow new studies for EXCESSIVE DAYTIME SLEEPINESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic sleepiness: Long-Term drug safety trial shows promise
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug pitolisant for adults with idiopathic hypersomnia, a condition causing excessive daytime sleepiness. Participants had already completed a previous pitolisant study. The goal was to see if the drug remains saf…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New drug shows promise for reducing narcolepsy attacks in long-term trial
Symptom relief CompletedThis study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who also have cataplexy (sudden muscle weakness) and excessive daytime sleepiness. The 68 participants had already completed an earlier study and continued taking AXS-12…
Matched conditions: EXCESSIVE DAYTIME SLEEPINESS
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC